These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28348461)

  • 1. AM966, an Antagonist of Lysophosphatidic Acid Receptor 1, Increases Lung Microvascular Endothelial Permeability through Activation of Rho Signaling Pathway and Phosphorylation of VE-Cadherin.
    Cai J; Wei J; Li S; Suber T; Zhao J
    Mediators Inflamm; 2017; 2017():6893560. PubMed ID: 28348461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model.
    Swaney JS; Chapman C; Correa LD; Stebbins KJ; Bundey RA; Prodanovich PC; Fagan P; Baccei CS; Santini AM; Hutchinson JH; Seiders TJ; Parr TA; Prasit P; Evans JF; Lorrain DS
    Br J Pharmacol; 2010 Aug; 160(7):1699-713. PubMed ID: 20649573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sevoflurane prevents lipopolysaccharide-induced barrier dysfunction in human lung microvascular endothelial cells: Rho-mediated alterations of VE-cadherin.
    Huang Y; Tan Q; Chen R; Cao B; Li W
    Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):119-24. PubMed ID: 26529544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RhoA and Rho-kinase dependent and independent signals mediate TGF-beta-induced pulmonary endothelial cytoskeletal reorganization and permeability.
    Clements RT; Minnear FL; Singer HA; Keller RS; Vincent PA
    Am J Physiol Lung Cell Mol Physiol; 2005 Feb; 288(2):L294-306. PubMed ID: 15475381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focal adhesion kinase and Src mediate microvascular hyperpermeability caused by fibrinogen- γC- terminal fragments.
    Guo X; Eitnier RA; Beard RS; Meegan JE; Yang X; Aponte AM; Wang F; Nelson PR; Wu MH
    PLoS One; 2020; 15(4):e0231739. PubMed ID: 32352989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposing effects of the angiopoietins on the thrombin-induced permeability of human pulmonary microvascular endothelial cells.
    van der Heijden M; van Nieuw Amerongen GP; van Bezu J; Paul MA; Groeneveld AB; van Hinsbergh VW
    PLoS One; 2011; 6(8):e23448. PubMed ID: 21858121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGF isoforms have differential effects on permeability of human pulmonary microvascular endothelial cells.
    Ourradi K; Blythe T; Jarrett C; Barratt SL; Welsh GI; Millar AB
    Respir Res; 2017 Jun; 18(1):116. PubMed ID: 28578669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of serum from patients with severe acute pancreatitis on vascular endothelial permeability.
    Zheng YJ; Zhou B; Ding G; Wang ZC; Wang XQ; Wang YL; Tang YQ
    Pancreas; 2013 May; 42(4):633-9. PubMed ID: 23303203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dephosphorylation of Y685-VE-Cadherin Involved in Pulmonary Microvascular Endothelial Barrier Injury Induced by Angiotensin II.
    Wu Z; Wang Z; Dai F; Liu H; Ren W; Chang J; Li B
    Mediators Inflamm; 2016; 2016():8696481. PubMed ID: 28119542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular heat shock protein 90α mediates HDM-induced bronchial epithelial barrier dysfunction by activating RhoA/MLC signaling.
    Dong HM; Le YQ; Wang YH; Zhao HJ; Huang CW; Hu YH; Luo LS; Wan X; Wei YL; Chu ZQ; Li W; Cai SX
    Respir Res; 2017 May; 18(1):111. PubMed ID: 28558721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory mechanism of ulinastatin: Inhibiting the hyperpermeability of vascular endothelial cells induced by TNF-α via the RhoA/ROCK signal pathway.
    Wei F; Liu S; Luo L; Gu N; Zeng Y; Chen X; Xu S; Zhang D
    Int Immunopharmacol; 2017 May; 46():220-227. PubMed ID: 28329735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes causes bone marrow endothelial barrier dysfunction by activation of the RhoA-Rho-associated kinase signaling pathway.
    Mangialardi G; Katare R; Oikawa A; Meloni M; Reni C; Emanueli C; Madeddu P
    Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):555-64. PubMed ID: 23307872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for VEGFR2 activation in endothelial responses caused by barrier disruptive OxPAPC concentrations.
    Birukova AA; Lee S; Starosta V; Wu T; Ho T; Kim J; Berliner JA; Birukov KG
    PLoS One; 2012; 7(1):e30957. PubMed ID: 22303475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel mechanism regulating endothelial permeability via T-cadherin-dependent VE-cadherin phosphorylation and clathrin-mediated endocytosis.
    Semina EV; Rubina KA; Sysoeva VY; Rutkevich PN; Kashirina NM; Tkachuk VA
    Mol Cell Biochem; 2014 Feb; 387(1-2):39-53. PubMed ID: 24136461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. α2-adrenoreceptor modulated FAK pathway induced by dexmedetomidine attenuates pulmonary microvascular hyper-permeability following kidney injury.
    Chen Q; Yi B; Ma J; Ning J; Wu L; Ma D; Lu K; Gu J
    Oncotarget; 2016 Aug; 7(35):55990-56001. PubMed ID: 27463003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ANP attenuates inflammatory signaling and Rho pathway of lung endothelial permeability induced by LPS and TNFalpha.
    Xing J; Birukova AA
    Microvasc Res; 2010 Jan; 79(1):56-62. PubMed ID: 19931545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysophosphatidic acid stimulates activation of focal adhesion kinase and paxillin and promotes cell motility, via LPA1-3, in human pancreatic cancer.
    Liao Y; Mu G; Zhang L; Zhou W; Zhang J; Yu H
    Dig Dis Sci; 2013 Dec; 58(12):3524-33. PubMed ID: 24061591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysophosphatidic acid enhances pulmonary epithelial barrier integrity and protects endotoxin-induced epithelial barrier disruption and lung injury.
    He D; Su Y; Usatyuk PV; Spannhake EW; Kogut P; Solway J; Natarajan V; Zhao Y
    J Biol Chem; 2009 Sep; 284(36):24123-32. PubMed ID: 19586906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of RAGE/ROCK1 Pathway in HMGB1-Induced Early Changes in Barrier Permeability of Human Pulmonary Microvascular Endothelial Cell.
    Zhao MJ; Jiang HR; Sun JW; Wang ZA; Hu B; Zhu CR; Yin XH; Chen MM; Ma XC; Zhao WD; Luan ZG
    Front Immunol; 2021; 12():697071. PubMed ID: 34745088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of endothelial cell permeability by high and low doses of oxidized 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphocholine.
    Starosta V; Wu T; Zimman A; Pham D; Tian X; Oskolkova O; Bochkov V; Berliner JA; Birukova AA; Birukov KG
    Am J Respir Cell Mol Biol; 2012 Mar; 46(3):331-41. PubMed ID: 21997484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.